FACIAL MUCORMYCOSIS COMPLICATING INDUCTIO N CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA

Background. - Most cases of mucormycosis occur in immunosuppressed chi ldren. Intracranial extension is lethal and must be prevented with ear ly specific treatment. Case report. - A 42 month-old boy was admitted suffering from acute lymphoblastic leukemia. Edema of the left eyelid developed on the sixth day of induction chemotherapy. Mucormycosis was suspected because of gradual extension of infection to nasal ala and periorbital area with fever, edema of nasal turbinates and nasal black secretions. Chemotherapy was discontinued and the patient was given i ntravenous amphotericin B (1.0 mg/kg/day) and heparin associated with G.CSF. Improvement was only temporary and scan examination performed o n day 17 showed involvement of the orbit, eye and wall of the maxillar y sinus; cultures of secretions were positive for staphylococcus and A bsidia corymbifera. Remission of leukemia was obtained a few days late r permitting surgical resection of involved tissues on day 30. A relap se of mucormycosis was observed six weeks later despite prolonged admi nistration of amphotericin B requiring extended resection of necrotic areas and replacement of amphotericin B by its liposomal form (Ambisom e(R)). Bone marrow relapse of leukemia required further chemotherapy. The patient is in good condition 30 months after the initial symptoms. Conclusion. - Our patient seems to be the first with prolonged remiss ion of facial mucormycosis and acute leukemia despite relapse of both diseases. This favorable outcome could be due to the use of Ambisome(R ).